Companies / Sarepta Therapeutics, Inc. / Activity

Activity — Sarepta Therapeutics, Inc.

15 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
RA Capital Management, L.P.
13F manager
NewCommon stock$84.92M+3.9M
3,902,596
3.69% of shares
high
Q1 2026
as of
Hotchkis and Wiley Capital Management, LLC
13F manager
NewCommon stock$12.19M+560K
560,150
0.53% of shares
medium
Q1 2026
as of
Intech Investment Management LLC
13F manager
NewCommon stock$932.6K+43K
42,857
0.04% of shares
low
Q1 2026
as of
Brighton Jones LLC
13F manager
NewCommon stock$717.9K+33K
32,993
0.03% of shares
low
Q1 2026
as of
Natixis
13F manager
NewCommon stock$497.3K+23K
22,856
0.02% of shares
low
Q3 2025
as of
Virtus Advisers, LLC
13F manager
NewCommon stock$497.2K+26K
25,800
0.02% of shares
low
Q1 2026
as of
Graham Capital Management, L.P.
13F manager
NewCommon stock$488.3K+22K
22,442
0.02% of shares
low
Q2 2025
as of
Boxer Capital Management, LLC
13F manager
NewCommon stock$427.5K+25K
25,000
0.02% of shares
low
Q1 2024
as of
Leonteq Securities AG
13F manager
NewCommon stock$95.5K+738
738
<0.01% of shares
low
Q2 2026
as of
Meeder Asset Management Inc
13F manager
NewCommon stock$27.1K+2K
1,507
<0.01% of shares
low
Q2 2025
as of
Elevation Point Wealth Partners, LLC
13F manager
NewCommon stock$8.1K+472
472
<0.01% of shares
low
Q1 2026
as of
Harbor Capital Advisors, Inc.
13F manager
NewCommon stock$1.7K+80K
80,085
0.08% of shares
low
Q2 2025
as of
Prestige Wealth Management Group LLC
13F manager
NewCommon stock$479+28
28
<0.01% of shares
low
Q2 2026
as of
CVA Family Office, LLC
13F manager
NewCommon stock$180+10
10
<0.01% of shares
low
Q4 2021
as of
Leonteq Securities AG
13F manager
NewCommon stock$90+1
1
<0.01% of shares
low
← PrevPage 1 of 1Next →